How To Spur Antibiotic Development? Higher Reimbursement, Govt. Funding Proposed By PCAST
This article was originally published in The Pink Sheet Daily
Executive Summary
President’s Council of Advisors on Science and Technology calls for establishment of infrastructure to support clinical trials and initiation of special medical use pathway; government to award $20 million prize for diagnostic to detect highly-resistant bacteria.
You may also be interested in...
Commercial, Reimbursement Hurdles Need To Be Addressed By Antimicrobial Resistance Efforts
Melinta describes difficulties launching its new antibiotics at BIO CEO & Investor Conference; companies and other stakeholders urge Congress to enact package of incentives to reinvigorate antibiotic pipeline.
Commercial, Reimbursement Hurdles Need To Be Addressed By Antimicrobial Resistance Efforts
Melinta describes difficulties launching its new antibiotics at BIO CEO & Investor Conference; companies and other stakeholders urge Congress to enact package of incentives to reinvigorate antibiotic pipeline.
Antibiotic Incentives: Pfizer’s Read Touts Exclusivity Voucher
Providing a transferable period of patent-life extension in exchange for US FDA approval of a new antibiotic would incentivize ‘the whole ecosystem’ to find new treatments for emerging diseases, CEO Ian Read says.